Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane Solomon

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
Cancer Discovery|May 16, 2012
Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa RicaRolando Herrero, Sholom Wacholder, Ana C Rodríguez, et al.
Sexually Transmitted Diseases|July 28, 2010
Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa RicaSarah Coseo, Carolina Porras, Allan Hildesheim, et al.
Sexually Transmitted Diseases|September 22, 2011
Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposureSarah E Coseo, Carolina Porras, Lori E Dodd, et al.
BMC Infectious Diseases|August 12, 2010
Determinants of seropositivity among HPV-16/18 DNA positive young womenCarolina Porras, Christina Bennett, Mahboobeh Safaeian, et al.
Plos One|July 23, 2013
Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa RicaRolando Herrero, Wim Quint, Allan Hildesheim, et al.
Cancer Research|April 1, 2010
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasiaMark Schiffman, Ana Cecilia Rodriguez, Zigui Chen, et al.
The Lancet. Oncology|August 26, 2011
Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine TrialAimée R Kreimer, Paula González, Hormuzd A Katki, et al.
The Journal of Infectious Diseases|August 2, 2012
Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa RicaFelipe A Castro, Wim Quint, Paula Gonzalez, et al.
Virology|May 26, 2005
The carcinogenicity of human papillomavirus types reflects viral evolutionMark Schiffman, Rolando Herrero, Rob Desalle, et al.
Vaccine|July 22, 2008
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa RicaRolando Herrero, Allan Hildesheim, Ana C Rodríguez, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Cancer Discovery|May 16, 2012
Prevention of persistent human papillomavirus infection by an HPV16/18 vaccine: a community-based randomized clinical trial in Guanacaste, Costa RicaRolando Herrero, Sholom Wacholder, Ana C Rodríguez, et al.
Sexually Transmitted Diseases|July 28, 2010
Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa RicaSarah Coseo, Carolina Porras, Allan Hildesheim, et al.
Sexually Transmitted Diseases|September 22, 2011
Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposureSarah E Coseo, Carolina Porras, Lori E Dodd, et al.
BMC Infectious Diseases|August 12, 2010
Determinants of seropositivity among HPV-16/18 DNA positive young womenCarolina Porras, Christina Bennett, Mahboobeh Safaeian, et al.
Plos One|July 23, 2013
Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa RicaRolando Herrero, Wim Quint, Allan Hildesheim, et al.
Cancer Research|April 1, 2010
A population-based prospective study of carcinogenic human papillomavirus variant lineages, viral persistence, and cervical neoplasiaMark Schiffman, Ana Cecilia Rodriguez, Zigui Chen, et al.
The Lancet. Oncology|August 26, 2011
Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine TrialAimée R Kreimer, Paula González, Hormuzd A Katki, et al.
The Journal of Infectious Diseases|August 2, 2012
Prevalence of and risk factors for anal human papillomavirus infection among young healthy women in Costa RicaFelipe A Castro, Wim Quint, Paula Gonzalez, et al.
Virology|May 26, 2005
The carcinogenicity of human papillomavirus types reflects viral evolutionMark Schiffman, Rolando Herrero, Rob Desalle, et al.
Vaccine|July 22, 2008
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa RicaRolando Herrero, Allan Hildesheim, Ana C Rodríguez, et al.
Pageof 10